GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » Current Accrued Expense

Alcon (ALC) Current Accrued Expense : $536 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Alcon Current Accrued Expense?

Alcon's Current Accrued Expense for the quarter that ended in Dec. 2023 was $536 Mil.

Alcon's quarterly Current Accrued Expense stayed the same from Jun. 2023 ($0 Mil) to Sep. 2023 ($0 Mil) but then increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($536 Mil).

Alcon's annual Current Accrued Expense increased from Dec. 2021 ($383 Mil) to Dec. 2022 ($536 Mil) but then stayed the same from Dec. 2022 ($536 Mil) to Dec. 2023 ($536 Mil).


Alcon Current Accrued Expense Historical Data

The historical data trend for Alcon's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon Current Accrued Expense Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial 330.00 317.00 383.00 536.00 536.00

Alcon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 536.00 - - - 536.00

Alcon Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Alcon Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Alcon's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Alcon (ALC) Business Description

Traded in Other Exchanges
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.